These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 7680170)
1. Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation. Mañez R; White LT; Kusne S; Martin M; Demetris AJ; Starzl TE; Duquesnoy RJ Transplant Proc; 1993 Feb; 25(1 Pt 2):908-9. PubMed ID: 7680170 [No Abstract] [Full Text] [Related]
2. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864 [TBL] [Abstract][Full Text] [Related]
3. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation. Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584 [TBL] [Abstract][Full Text] [Related]
4. Role of the graft as a source of donor-type microchimerism in liver transplant patients. Hisanaga M; Schlitt HJ; Hundrieser J; Nakajima Y; Kanehiro H; Nakano H; Pichlmayr R Transplant Proc; 1996 Apr; 28(2):1073-5. PubMed ID: 8623231 [No Abstract] [Full Text] [Related]
5. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease. Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360 [No Abstract] [Full Text] [Related]
6. Reversal of chronic rejection after treatment failure with FK506 and RS61443. Roberts JP; Lake JR; Hebert M; Nikolai B; Ascher NL; Ferrell LD Transplantation; 1993 Oct; 56(4):1021-3. PubMed ID: 7692634 [No Abstract] [Full Text] [Related]
7. Influence of donor-recipient HLA-DR mismatches and OKT3 prophylaxis on cadaver kidney graft survival. Vereerstraeten P; Dupont E; Andrien M; De Pauw L; Abramowicz D; Goldman M; Kinnaert P Transplantation; 1995 Aug; 60(3):253-8. PubMed ID: 7645038 [TBL] [Abstract][Full Text] [Related]
8. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors. Oertel M; Berr F; Schröder S; Schwarz R; Tannapfel A; Wenzke M; Lamesch P; Hauss J; Kohlhaw K Liver Transpl; 2000 Nov; 6(6):728-33. PubMed ID: 11084059 [TBL] [Abstract][Full Text] [Related]
9. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Araújo MB; Leonardi LS; Boin IF; Leonardi MI; Magna LA; Donadi EA; Kraemer MH Transplant Proc; 2004 May; 36(4):953-5. PubMed ID: 15194331 [TBL] [Abstract][Full Text] [Related]
10. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213 [No Abstract] [Full Text] [Related]
11. FK 506 used as rescue therapy for refractory liver allograft rejection. Chen CL; Eng HL; Chen YS; Kuo YC; Sun CK Transplant Proc; 1994 Aug; 26(4):1927-9. PubMed ID: 7520612 [No Abstract] [Full Text] [Related]
13. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation. Chen M; Wade J; Levy GA; Greig PD Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844 [No Abstract] [Full Text] [Related]
14. Severity of liver transplantation rejection is associated with recipient HLA type. Doran TJ; Derley L; Chapman J; McCaughan G; Painter D; Dorney S; Sheil AG Transplant Proc; 1992 Feb; 24(1):192-3. PubMed ID: 1539240 [No Abstract] [Full Text] [Related]
16. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279 [No Abstract] [Full Text] [Related]
17. Effect of HLA matching on graft survival in live donor kidney transplantations. Velidedeoğlu E; Bilgin N; Haberal M Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491 [No Abstract] [Full Text] [Related]
18. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients. Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603 [TBL] [Abstract][Full Text] [Related]
19. HLA matching in liver transplantation: a retrospective analysis. Gunson BK; Hathaway M; Buckels JA; Mayer AD; Elias E; McMaster P; Neuberger JM Transplant Proc; 1992 Dec; 24(6):2434-5. PubMed ID: 1465819 [No Abstract] [Full Text] [Related]
20. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]